Summary

Auf Papier basierende Vorrichtungen zur Isolierung und Charakterisierung von extrazellulärer Vesikel

Published: April 03, 2015
doi:

Summary

Diese Protokollinformationen ein Verfahren zur extrazellulären Vesikeln (EVs), kleine membranöse Teilchen aus Zellen freigesetzt zu isolieren, von so wenig wie 10 ul Serumproben. Dieser Ansatz umgeht die Notwendigkeit von Ultrazentrifugation, nur wenige Minuten von Testzeit erfordert und ermöglicht die Isolation von Elektrofahrzeugen aus Proben von begrenzten Mengen.

Abstract

Extrazellulären Vesikeln (EVs), membranartige Partikel aus verschiedenen Arten von Zellen freigesetzt, halten ein großes Potenzial für die klinische Anwendung. Sie enthalten von Nukleinsäuren und Proteinen Ladung und werden zunehmend als Mittel zur interzellulären Kommunikation sowohl eukaryote und prokaryote Zellen verwendet erfasst. Aufgrund ihrer geringen Größe, aktuelle Protokolle zur Isolierung von Elektrofahrzeugen sind oft zeitaufwendig, umständlich und erfordert große Probenvolumina und teure Ausrüstung, wie zum Beispiel einer Ultrazentrifuge. Um diese Einschränkungen zu begegnen, haben wir eine papierbasierte Immunaffinitäts Plattform zur Trennung von Untergruppen von Elektrofahrzeugen, die einfach, effizient ist und erfordert Probenvolumen von nur 10 & mgr; l. Biologische Proben können direkt auf Papier Testzonen, die chemisch mit Fängermolekülen, die eine hohe Affinität zu bestimmten EV Oberflächenmarker haben die modifiziert wurden, pipettiert werden. Wir bestätigen die Assays unter Verwendung von Rasterelektronenmikroskopie (SEM), auf Papierbasis enzymgebundenen immunosorbent-Tests (P-ELISA) und Transkriptom-Analyse. Diese Papier-basierte Geräte ermöglichen das Studium von Elektrofahrzeugen in der Klinik und der Forschung Einstellung zu helfen unser Verständnis von EV-Funktionen in Gesundheit und Krankheit.

Introduction

Extracellular vesicles (EVs) are heterogeneous membranous particles that range in size from 40 nm to 5,000 nm and are released actively by many cell types via different biogenesis routes1-9. They contain unique and selected subsets of DNA, RNA, proteins, and surface markers from parental cells. Their involvement in a variety of cellular processes, such as intercellular communication10, immunity modulation11, angiogenesis12, metastasis12, chemoresistance13, and the development of eye diseases9, is increasingly recognized and has spurred a great interest in their utility in diagnostic, prognostic, therapeutic, and basic biology applications.

EVs can be classically categorized as exosomes, microvesicles, apoptotic bodies, oncosomes, ectosomes, microparticles, telerosomes, prostatosomes, cardiosomes, and vexosomes, etc., based on their biogenesis or cellular origin. For example, exosomes are formed in multivesicular bodies, whereas microvesicles are generated by budding directly from plasma membrane and apoptotic vesicles are from apoptotic or necrotic cells. However, the nomenclature is still under refined, partly due to a lack of thorough understanding and characterization of EVs. Several methods have been developed to purify EVs, including ultracentrifugation14, ultrafiltration15, magnetic beads16, polymeric precipitation17-19, and microfluidic techniques20-22. The most common procedure to purify EVs involves a series of centrifugations and/or filtration to remove large debris and other cellular contaminants, followed by a final high-speed ultracentrifugation, a process that is expensive, tedious, and nonspecific14,23,24. Unfortunately, technological need for rapid and reliable isolation of EVs with satisfactory purity and efficiency is not yet met.

We have developed a paper-based immunoaffinity device that provides a simple, time- and cost-saving, yet efficient way to isolate and characterize subgroups of EVs22. Cellulose paper cut into a defined shape can be arranged and laminated using two plastic sheets with registered through-holes. In contrast to the general strategy to define the fluid boundary in paper-based devices by printing hydrophobic wax or polymers25-27, these laminated paper patterns are resistant to many organic liquids, including ethanol. Paper test zones are chemically modified to provide stable and dense coverage of capture molecules (e.g., target-specific antibodies) that have high affinity to specific surface markers on EV subgroups. Biological samples can be pipetted directly onto the paper test zones, and purified EVs are retained after rinse steps. Characterization of isolated EVs can be performed by SEM, ELISA, and transcriptomic analysis.

Protocol

Ein allgemeines Diagramm des Betriebs ist in Abbildung 1 zur Verfügung gestellt. Mit ethischen Praktiken, sammelten wir Blutproben von gesunden Probanden und erhalten Kammerwasser-Proben von Patienten durch die Taichung Veterans General Hospital (TCVGH), Taichung, Taiwan unter IRB zugelassen Protokolle ( IRB TCVGH Nr CF11213-1). 1. Herstellung von Papier Material Geschnitten Chromatographiepapier in Kreise von 5 mm im Durchmesser, um das gleiche Layout wie einer 96-Well-Mikrotiterpla…

Representative Results

Die Fähigkeit des Papiers Gerät Gruppen von EVs isolieren stützt effizient auf seine empfindliche und spezifische Erkennung von EV-Oberflächenmarker. Die stabile Modifikation von Papierfasern mit Fängermolekülen wird durch die Verwendung von Avidin-Biotin-Chemie als anderswo 28-30 beschrieben ist. Die Wirksamkeit der chemischen Konjugation, und dass der Physisorption Verfahren unter Anwendung der fluoreszenzbasierten Auslesungen beurteilt. Die Papier Prüfzonen folgenden Protokoll Schritt 1) ​​mit A…

Discussion

Die wichtigsten Schritte zur erfolgreichen Isolierung von Untergruppen von extrazellulären Vesikeln sind: 1) eine gute Wahl des Papiers; 2) stabile und hohe Abdeckung der Fängermoleküle auf der Oberfläche der Papierfasern; 3) die richtige Handhabung der Proben; und 4) allgemeine Laborhygienemaßnahmen.

Poröse Materialien haben sich in vielen preiswerten und Ausrüstung freien Tests genutzt. Sie haben abstimmbare Porengrße, vielseitige Funktionalität, niedrige Kosten und hohe Oberfläc…

Disclosures

The authors have nothing to disclose.

Acknowledgements

Diese Arbeit wurde zum Teil durch die National Science Council Taiwan-Beihilfen NSC 99-2320-B-007-005-MY2 (CC) und NSC 101-2628-E-007-011-MY3 (CMC), und der Veterans General unterstützt Krankenhäuser und Universitätssystem von Taiwan Joint Research Programme (CC).

Materials

Chromatography Paper GE Healthcare Life Sciences 3001-861  Whatman® Grade 1 cellulose paper
(3-Mercaptopropyl) trimethoxysilane Sigma Aldrich 175617 This chemical reacts with water and moisture and should be applied inside a nitrogen-filled glove bag. Avoid eye and skin contact. Do not breathe fumes or inhale vapors.
Ethanol Fisher Scientific BP2818 Absolute, 200 Proof, molecular biology grade
Bovine serum albumin (BSA) BioShop Canada Inc. ALB001 Often referred to as Cohn fraction V.
N-g-maleimidobutyryloxy succinimide ester (GMBS) Pierce Biotechnology 22309 GMBS is an amine-to-sulfhydryl crosslinker. GMBS is moisture-sensitive.
Avidin Pierce Biotechnology 31000 NeutrAvidin has 4 binding sites for biotin and its pI value is 6.3, which is more neutral than native avidin
Biotinylated mouse anti-human anti-CD63 Ancell 215-030 clone AHN16.1/46-4-5
biotinylated annexin V BD Biosciences 556418 Annxin V has a high affinity for phosphotidylserine (PS)
Primary anti-CD9 and secondary antibody System Biosciences EXOAB-CD9A-1 The secondary antibody is horseradish peroxidise-conjugated
Serum separation tubes BD Biosciences 367991 Clot activator and gel for serum separation
Annexin V binding buffer BD Biosciences 556454 10X; dilute to 1X prior to use.
TMB substrate reagent set BD Biosciences 555214 The set contains hydrogen peroxide and 3,3’,5,5’-tetramethylbenzidine (TMB)
RNA isolation kit Life Technologies AM1560 MirVana RNA isolation kit
Polyvinylpyrrolidone-based RNA isolation aid Life Technologies AM9690 Plant RNA isolation aid contains polyvinylpyrrolidone (PVP) that binds to polysaccharides.
RNA cleanup kit Qiagen Inc. 74004 MinElute RNA cleanup kit is designed for purification of up to 45 μg RNA.
Plasma chamber March Instruments PX-250
Scanning electron microscope Hitachi Ltd. S-4300
Desktop scanner Hewlett-Packard Company Photosmart B110 8-bit color images were captured. Cameras and smart phones may be also used.
Image-record system J&H Technology Co GeneSys G:BOX Chemi-XX8 16-bit fluroscence images were captured. Fluroscence microscopes may be also used.

References

  1. Caby, M. P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., Bonnerot, C. Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 17, 879-887 (2005).
  2. Lasser, C., et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J. Transl. Med. 9, 9 (2011).
  3. Raj, D. A. A., Fiume, I., Capasso, G., Pocsfalvi, G. A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. Kidney Int. 81, 1263-1272 (2012).
  4. Wiggins, R. C., Glatfelter, A., Kshirsagar, B., Brukman, J. Procoagulant activity in normal human-urine associated with subcellular particles. Kidney Int. 29, 591-597 (1986).
  5. Admyre, C., et al. Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 179, 1969-1978 (2007).
  6. Keller, S., Ridinger, J., Rupp, A. K., Janssen, J. W. G., Altevogt, P. Body fluid derived exosomes as a novel template for clinical diagnostics. J. Transl. Med. 9, 86 (2011).
  7. Asea, A., et al. Heat shock protein-containing exosomes in mid-trimester amniotic fluids. J. Reprod. Immunol. 79, 12-17 (2008).
  8. Bard, M. P., et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Resp. Cell Mol. Biol. 31, 114-121 (2004).
  9. Perkumas, K. M., Hoffman, E. A., McKay, B. S., Allingham, R. R., Stamer, W. D. Myocilin-associated exosomes in human ocular samples. Exp. Eye Res. 84, 209-212 (2007).
  10. Anderson, H. C., Mulhall, D., Garimella, R. Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab. Invest. 90, 1549-1557 (2010).
  11. Montecalvo, A., et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood. 119, 756-766 (2012).
  12. Grange, C., et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 71, 5346-5356 (2011).
  13. Jaiswal, R., et al. Microparticle-associated nucleic acids mediate trait dominance in cancer. Faseb. J. 26, 420-429 (2012).
  14. Thery, C., Clayton, A., Amigorena, S., Raposo, G., Morgan, K. K. . Current protocols in cell biology. (UNIT 3.22), (2006).
  15. Rood, I. M., et al. Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int. 78, 810-816 (2010).
  16. Taylor, D. D., Gercel-Taylor, C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21 (2008).
  17. Witwer, K. W., et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracellular Vesicles. 2, 20360 (2013).
  18. Fernandez-Llama, P., et al. Tamm-Horsfall protein and urinary exosome isolation. Kidney Int. 77, 736-742 (2010).
  19. Alvarez, M. L., Khosroheidari, M., Ravi, R. K., DiStefano, J. K. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 82, 1024-1032 (2012).
  20. Chen, C., et al. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab. Chip. 10, 505-511 (2010).
  21. Davies, R. T., et al. Microfluidic filtration system to isolate extracellular vesicles from blood. Lab. Chip. 12, 5202-5210 (2012).
  22. Chen, C., et al. Paper-based immunoaffinity devices for accessible isolation and characterization of extracellular vesicles. Microfluid. Nanofluid. 16, 849-856 (2014).
  23. Lamparski, H. G., et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods. 270, 211-226 (2002).
  24. Cantin, R., Diou, J., Belanger, D., Tremblay, A. M., Gilbert, C. Discrimination between exosomes and HIV-1: Purification of both vesicles from cell-free supernatants. J. Immunol. Methods. 338, 21-30 (2008).
  25. Carrilho, E., Martinez, A. W., Whitesides, G. M. Understanding wax printing: a simple micropatterning process for paper-based microfluidics. Anal. Chem. 81, 7091-7095 (2009).
  26. Dungchai, W., Chailapakul, O., Henry, C. S. Electrochemical detection for paper-based microfluidics. Anal. Chem. 81, 5821-5826 (2009).
  27. Glavan, A. C., et al. Omniphobic ‘R-F paper’ produced by silanization of paper with fluoroalkyltrichlorosilanes. Adv. Funct. Mater. 24, 60-70 (2014).
  28. Usami, S., Chen, H. H., Zhao, Y. H., Chien, S., Skalak, R. Design and construction of a linear shear-stress flow chamber. Ann. Biomed. Eng. 21, 77-83 (1993).
  29. Murthy, S. K., Sin, A., Tompkins, R. G., Toner, M. Effect of flow and surface conditions on human lymphocyte isolation using microfluidic chambers. Langmuir. 20, 11649-11655 (2004).
  30. Cras, J. J., Rowe-Taitt, C. A., Nivens, D. A., Ligler, F. S. Comparison of chemical cleaning methods of glass in preparation for silanization. Biosens. Bioelectron. 14, 683-688 (1999).
  31. Thery, C., Zitvogel, L., Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579 (2002).
  32. Scanu, A., et al. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins. J. Leukocyte Biol. 83, 921-927 (2008).
  33. Inal, J. M., et al. Microvesicles in health and disease. Arch. Immunol. Ther. Ex. 60, 107-121 (2012).
  34. Fridley, G. E., Holstein, C. A., Oza, S. B., Yager, P. The evolution of nitrocellulose as a material for bioassays. Mrs Bull. 38, 326-330 (2013).
  35. Gyorgy, B., et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell. Mol. Life Sci. 68, 2667-2688 (2011).
  36. Missoum, K., Belgacem, M. N., Bras, J. Nanofibrillated cellulose surface modification: a review. Materials. 6, 1745-1766 (2013).
  37. Kalia, S., Boufi, S., Celli, A., Kango, S. Nanofibrillated cellulose: surface modification and potential applications. Colloid Polym. Sci. 292, 5-31 (2014).
check_url/kr/52722?article_type=t

Play Video

Cite This Article
Chen, C., Lin, B., Hsu, M., Cheng, C. Paper-based Devices for Isolation and Characterization of Extracellular Vesicles. J. Vis. Exp. (98), e52722, doi:10.3791/52722 (2015).

View Video